{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:50Z","timestamp":1787020850564,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aortic stiffness index (AoSI) has to be considered a proxy outcome measure in patients with rheumatoid arthritis (RA). The aim of this study was to comparatively describe AoSI progression in two groups of RA patients on long-term treatment with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) with or without tumour necrosis factor inhibitors (TNFi).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>AoSI was evaluated by Doppler echocardiography at the level of the aortic root, using a two-dimensional guided M-mode evaluation. Eligible participants were assessed at baseline and after 12 months. Changes in serum lipids, glucose and arterial blood pressure were assessed. All patients who did not change DMARD treatment during follow-up were consecutively selected for this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 107 (64 TNFi and 43 csDMARDs) RA patients. Most patients (74%) were in remission or low disease activity and had some CVD risk factors (45.8% hypertension, 59.8% dyslipidaemia, 45.3% smoking). The two groups did not differ significantly for baseline AoSI (5.95\u00b13.73% vs 6.08\u00b14.20%,\n                      <jats:italic>p<\/jats:italic>\n                      =0.867). Follow-up AoSI was significantly increased from baseline in the csDMARDs group (+1.00%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001) but not in the TNFi group (+0.15%,\n                      <jats:italic>p<\/jats:italic>\n                      =0.477). Patients on TNFi had significantly lower follow-up AoSI from baseline than the csDMARDs group (\u22121.02%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001; ANCOVA corrected for baseline AoSI, age and systolic blood pressure). Furthermore, follow-up AoSI was significantly lower in TNFi than in csDMARDs users with an increasing number of CVD risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Long-term treatment with TNFi was associated with reduced aortic stiffness progression in patients with established RA and several CVD risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-021-02546-3","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:32:02Z","timestamp":1622687522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-7673","authenticated-orcid":false,"given":"Alessandro","family":"Giollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ognibeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Orsolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dalbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bixio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Fassio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"issue":"9","key":"2546_CR1","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avi\u00f1a-Zubieta","year":"2012","unstructured":"Avi\u00f1a-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"2546_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008 Dec 15;59(12):1690\u20137. https:\/\/doi.org\/10.1002\/art.24092.","journal-title":"Arthritis Rheum."},{"issue":"5","key":"2546_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.62.5.414","volume":"62","author":"R Klocke","year":"2003","unstructured":"Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis. 2003 May;62(5):414\u20138. https:\/\/doi.org\/10.1136\/ard.62.5.414.","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"2546_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jbspin.2014.01.014","volume":"81","author":"C Prati","year":"2014","unstructured":"Prati C, Demougeot C, Guillot X, Godfrin-Valnet M, Wendling D. Endothelial dysfunction in joint disease. Joint Bone Spine. 2014 Feb 22;81(5):386\u201391. https:\/\/doi.org\/10.1016\/j.jbspin.2014.01.014.","journal-title":"Joint Bone Spine."},{"issue":"6","key":"2546_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00005-017-0465-7","volume":"65","author":"L Moroni","year":"2017","unstructured":"Moroni L, Selmi C, Angelini C, Meroni PL. Evaluation of endothelial function by flow-mediated dilation: a comprehensive review in rheumatic disease. Arch Immunol Ther Exp. 2017 Dec;65(6):463\u201375. https:\/\/doi.org\/10.1007\/s00005-017-0465-7.","journal-title":"Arch Immunol Ther Exp."},{"issue":"1","key":"2546_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1570161114666161013113457","volume":"15","author":"K Kotani","year":"2017","unstructured":"Kotani K, Miyamoto M, Ando H. The effect of treatments for rheumatoid arthritis on endothelial dysfunction evaluated by flow-mediated vasodilation in patients with rheumatoid arthritis. Curr Vasc Pharmacol. 2017;15(1):10\u20138. https:\/\/doi.org\/10.2174\/1570161114666161013113457.","journal-title":"Curr Vasc Pharmacol."},{"issue":"2","key":"2546_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","volume":"38","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum. 2008 Oct;38(2):67\u201370. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.02.001.","journal-title":"Semin Arthritis Rheum."},{"issue":"7","key":"2546_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41584-018-0022-8","volume":"14","author":"R Bordy","year":"2018","unstructured":"Bordy R, Totoson P, Prati C, Marie C, Wendling D, Demougeot C. Microvascular endothelial dysfunction in rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(7):404\u201320. https:\/\/doi.org\/10.1038\/s41584-018-0022-8.","journal-title":"Nat Rev Rheumatol."},{"issue":"14","key":"2546_CR9","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jacc.2010.12.017","volume":"57","author":"JL Cavalcante","year":"2011","unstructured":"Cavalcante JL, Lima JAC, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011 Apr 5;57(14):1511\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2010.12.017.","journal-title":"J Am Coll Cardiol."},{"issue":"25 Suppl 1","key":"2546_CR10","doi-asserted-by":"publisher","first-page":"IV31","DOI":"10.1161\/01.CIR.0000133442.99186.39","volume":"109","author":"JN Cohn","year":"2004","unstructured":"Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004 Jun 29;109(25 Suppl 1):IV31\u201346. https:\/\/doi.org\/10.1161\/01.CIR.0000133442.99186.39.","journal-title":"Circulation."},{"issue":"13","key":"2546_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1318\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.061.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"2546_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/ATVBAHA.119.313132","volume":"40","author":"P Segers","year":"2020","unstructured":"Segers P, Rietzschel ER, Chirinos JA. How to measure arterial stiffness in humans. Arterioscler Thromb Vasc Biol. 2020 May;40(5):1034\u201343. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313132.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"9","key":"2546_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jacc.2019.07.012","volume":"74","author":"JA Chirinos","year":"2019","unstructured":"Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(9):1237\u201363. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.012.","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"2546_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3899\/jrheum.171128","volume":"45","author":"LH-P Tam","year":"2018","unstructured":"Tam LH-P, Shang Q, Li EK-M, Wong PC-H, Kwok KY, Kun EW-L, et al. Effect of treat-to-target strategies aiming at remission of arterial stiffness in early rheumatoid arthritis: a randomized controlled study. J Rheumatol. 2018;45(9):1229\u201339. https:\/\/doi.org\/10.3899\/jrheum.171128.","journal-title":"J Rheumatol."},{"issue":"1","key":"2546_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jjcc.2011.09.004","volume":"59","author":"G Kocabay","year":"2012","unstructured":"Kocabay G, Hasdemir H, Yildiz M. Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Beh\u00e7et\u2019s disease. Journal of Cardiology. 2012 Jan 1;59(1):72\u20137. https:\/\/doi.org\/10.1016\/j.jjcc.2011.09.004.","journal-title":"Journal of Cardiology."},{"issue":"5","key":"2546_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/ard.2010.141523","volume":"70","author":"SA Provan","year":"2011","unstructured":"Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis. 2011 May 1;70(5):812\u20137. https:\/\/doi.org\/10.1136\/ard.2010.141523.","journal-title":"Ann Rheum Dis."},{"issue":"17","key":"2546_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1177\/2047487316649762","volume":"23","author":"G Cioffi","year":"2016","unstructured":"Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Orsolini G, Adami S, et al. Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness. Eur J Prev Cardiolog. 2016 Nov 1;23(17):1848\u201359. https:\/\/doi.org\/10.1177\/2047487316649762.","journal-title":"Eur J Prev Cardiolog."},{"issue":"12","key":"2546_CR18","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3899\/jrheum.120541","volume":"39","author":"L-S Tam","year":"2012","unstructured":"Tam L-S, Shang Q, Li EK, Wang S, Li R-J, Lee K-L, et al. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis\u2014a randomized trial. J Rheumatol. 2012 Dec 1;39(12):2267\u201375. https:\/\/doi.org\/10.3899\/jrheum.120541.","journal-title":"J Rheumatol."},{"issue":"11","key":"2546_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/annrheumdis-2020-217653","volume":"79","author":"S Plein","year":"2020","unstructured":"Plein S, Erhayiem B, Fent G, Horton S, Dumitru RB, Andrews J, et al. Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-na\u00efve, early rheumatoid arthritis. Ann Rheum Dis. 2020 Nov;79(11):1414\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217653.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2546_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/annrheumdis-2018-214075","volume":"78","author":"B Burggraaf","year":"2019","unstructured":"Burggraaf B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, Liem AH, van de Geijn G-JM, et al. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis. 2019;78(3):335\u201341. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214075.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"2546_CR21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/rheumatology\/kew306","volume":"55","author":"L-A Bissell","year":"2016","unstructured":"Bissell L-A, Hensor EMA, Kozera L, Mackie SL, Burska AN, Nam JL, et al. Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study. Rheumatology. 2016 Dec;55(12):2181\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/kew306.","journal-title":"Rheumatology."},{"issue":"1","key":"2546_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/art.39833","volume":"69","author":"C Charles-Schoeman","year":"2017","unstructured":"Charles-Schoeman C, Yin Lee Y, Shahbazian A, Wang X, Elashoff D, Curtis JR, et al. Improvement of high-density lipoprotein function in patients with early rheumatoid arthritis treated with methotrexate monotherapy or combination therapies in a randomized controlled trial. Arthritis Rheumatol. 2017;69(1):46\u201357. https:\/\/doi.org\/10.1002\/art.39833.","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"2546_CR23","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/kez114","volume":"58","author":"I Mortimer","year":"2019","unstructured":"Mortimer I, Bissell L-A, Hensor EMA, Kozera L, Mackie SL, Burska AN, et al. Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology. 2019;58(9):1684\u20136.","journal-title":"Rheumatology"},{"issue":"1","key":"2546_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/acr.23094","volume":"69","author":"K Jafri","year":"2017","unstructured":"Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A. Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res. 2017;69(1):51\u20137. https:\/\/doi.org\/10.1002\/acr.23094.","journal-title":"Arthritis Care Res."},{"issue":"1","key":"2546_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010 Jan;69(1):70\u201381. https:\/\/doi.org\/10.1136\/ard.2008.096487.","journal-title":"Ann Rheum Dis."},{"key":"2546_CR26","doi-asserted-by":"crossref","unstructured":"England BR, Roul P, Yang Y, Sayles H, Yu F, Michaud K, et al. Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015. Ann Rheum Dis. 2021;80:286-92.","DOI":"10.1136\/annrheumdis-2020-218282"},{"issue":"4","key":"2546_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/eurheartj\/ehm528","volume":"29","author":"S Nistri","year":"2008","unstructured":"Nistri S, Grande-Allen J, Noale M, Basso C, Siviero P, Maggi S, et al. Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J. 2008 Feb;29(4):472\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehm528.","journal-title":"Eur Heart J."},{"issue":"11","key":"2546_CR28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/oxfordjournals.eurheartj.a059639","volume":"11","author":"C Stefanadis","year":"1990","unstructured":"Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J. 1990 Nov;11(11):990\u20136. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a059639.","journal-title":"Eur Heart J."},{"key":"2546_CR29","doi-asserted-by":"publisher","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036. https:\/\/doi.org\/10.1136\/bmj.k1036.","DOI":"10.1136\/bmj.k1036"},{"issue":"7","key":"2546_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/rheumatology\/kem089","volume":"46","author":"F Del Porto","year":"2007","unstructured":"Del Porto F, Lagan\u00e0 B, Lai S, Nofroni I, Tinti F, Vitale M, et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology. 2007 Jul 1;46(7):1111\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kem089.","journal-title":"Rheumatology."},{"issue":"3","key":"2546_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3899\/jrheum.090417","volume":"37","author":"B Galarraga","year":"2010","unstructured":"Galarraga B, Belch JJF, Pullar T, Ogston S, Khan F. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J Rheumatol. 2010 Mar;37(3):521\u20138. https:\/\/doi.org\/10.3899\/jrheum.090417.","journal-title":"J Rheumatol."},{"key":"2546_CR32","doi-asserted-by":"publisher","unstructured":"Spinelli FR, Metere A, Barbati C, Pierdominici M, Iannuccelli C, Lucchino B, et al. Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis. Mediators Inflamm. 2013;2013(537539). https:\/\/doi.org\/10.1155\/2013\/537539.","DOI":"10.1155\/2013\/537539"},{"issue":"7","key":"2546_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14740338.2018.1483331","volume":"17","author":"A Giollo","year":"2018","unstructured":"Giollo A, Bissell L-A, Buch MH. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review. Expert Opin Drug Saf. 2018;17(7):697\u2013708. https:\/\/doi.org\/10.1080\/14740338.2018.1483331.","journal-title":"Expert Opin Drug Saf."},{"issue":"12","key":"2546_CR34","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID Del Rinc\u00f3n","year":"2001","unstructured":"Del Rinc\u00f3n ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737\u201345. https:\/\/doi.org\/10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2546_CR35","doi-asserted-by":"publisher","first-page":"e0117952","DOI":"10.1371\/journal.pone.0117952","volume":"10","author":"LR Baghdadi","year":"2015","unstructured":"Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117952. https:\/\/doi.org\/10.1371\/journal.pone.0117952.","journal-title":"PLoS One."},{"issue":"4","key":"2546_CR36","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, M\u00f6ller B, Ljung L, Magnusson S, Smedby T, S\u00f6dergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011;13(4):R131. https:\/\/doi.org\/10.1186\/ar3442.","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"2546_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/ard.2009.124180","volume":"69","author":"NB Klarenbeek","year":"2010","unstructured":"Klarenbeek NB, van der Kooij SM, Huizinga TJW, Goekoop-Ruiterman YPM, Hulsmans HMJ, van Krugten MV, et al. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial. Ann Rheum Dis. 2010 Jul;69(7):1342\u20135. https:\/\/doi.org\/10.1136\/ard.2009.124180.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2546_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/EDE.0000000000000446","volume":"27","author":"RJ Desai","year":"2016","unstructured":"Desai RJ, Solomon DH, Schneeweiss S, Danaei G, Liao KP, Kim SC. Tumor necrosis factor-\u03b1 inhibitor use and the risk of incident hypertension in patients with rheumatoid arthritis. Epidemiology. 2016 May;27(3):414\u201322. https:\/\/doi.org\/10.1097\/EDE.0000000000000446.","journal-title":"Epidemiology."},{"issue":"1","key":"2546_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.38894","volume":"67","author":"A Souto","year":"2015","unstructured":"Souto A, Salgado E, Maneiro JR, Mera A, Carmona L, G\u00f3mez-Reino JJ. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol. 2015 Jan;67(1):117\u201327. https:\/\/doi.org\/10.1002\/art.38894.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"2546_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.41095","volume":"72","author":"JT Giles","year":"2020","unstructured":"Giles JT, Sattar N, Gabriel S, Ridker PM, Gay S, Warne C, et al. Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol. 2020;72(1):31\u201340. https:\/\/doi.org\/10.1002\/art.41095.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"2546_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","volume":"77","author":"C Rempenault","year":"2018","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, et al. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2018 Jan;77(1):98\u2013103. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211836.","journal-title":"Ann Rheum Dis."},{"issue":"24","key":"2546_CR42","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011 Jun 22;305(24):2525\u201331. https:\/\/doi.org\/10.1001\/jama.2011.878.","journal-title":"JAMA."},{"issue":"1","key":"2546_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, K\u00e4llberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006 Jan;54(1):38\u201346. https:\/\/doi.org\/10.1002\/art.21575.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"2546_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.2008.102962","volume":"69","author":"EW Karlson","year":"2010","unstructured":"Karlson EW, Chang S-C, Cui J, Chibnik LB, Fraser PA, De Vivo I, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010 Jan;69(1):54\u201360. https:\/\/doi.org\/10.1136\/ard.2008.102962.","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"2546_CR45","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008 Oct;67(10):1488\u201392. https:\/\/doi.org\/10.1136\/ard.2007.075192.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"2546_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir S, Wedr\u00e9n S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum. 2011;63(1):26\u201336. https:\/\/doi.org\/10.1002\/art.27758.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"2546_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.CIR.76.1.6","volume":"76","author":"J Nowak","year":"1987","unstructured":"Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 1987 Jul 1;76(1):6\u201314. https:\/\/doi.org\/10.1161\/01.CIR.76.1.6.","journal-title":"Circulation."},{"issue":"1","key":"2546_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/01.CIR.95.1.31","volume":"95","author":"S Christodoulos","year":"1997","unstructured":"Christodoulos S, Eleftherios T, Charalambos V, Costas S, Konstantinos T, Christos P, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997 Jan 7;95(1):31\u20138.","journal-title":"Circulation."},{"issue":"3","key":"2546_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJM199601183340303","volume":"334","author":"DS Celermajer","year":"1996","unstructured":"Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. NEJM. 1996 Jan 18;334(3):150\u20134. https:\/\/doi.org\/10.1056\/NEJM199601183340303.","journal-title":"NEJM."},{"issue":"16","key":"2546_CR50","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/hc4101.097525","volume":"104","author":"RS Barua","year":"2001","unstructured":"Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001 Oct 16;104(16):1905\u201310. https:\/\/doi.org\/10.1161\/hc4101.097525.","journal-title":"Circulation."},{"issue":"4","key":"2546_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0735-1097(98)00010-2","volume":"31","author":"H Sumida","year":"1998","unstructured":"Sumida H, Watanabe H, Kugiyama K, Ohgushi M, Matsumura T, Yasue H. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol. 1998 Mar 15;31(4):811\u20135. https:\/\/doi.org\/10.1016\/S0735-1097(98)00010-2.","journal-title":"J Am Coll Cardiol."},{"issue":"11","key":"2546_CR52","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.CIR.102.11.1233","volume":"102","author":"PA Kaufmann","year":"2000","unstructured":"Kaufmann PA. Gnecchi-Ruscone Tomaso, di Terlizzi Marco, Sch\u00e4fers Klaus P., L\u00fcscher Thomas F., Camici Paolo G. Coronary heart disease in smokers. Circulation. 2000 Sep 12;102(11):1233\u20138. https:\/\/doi.org\/10.1161\/01.CIR.102.11.1233.","journal-title":"Circulation."},{"issue":"5 Pt 1","key":"2546_CR53","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","volume":"88","author":"DS Celermajer","year":"1993","unstructured":"Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993 Nov;88(5 Pt 1):2149\u201355. https:\/\/doi.org\/10.1161\/01.CIR.88.5.2149.","journal-title":"Circulation."},{"issue":"18","key":"2546_CR54","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jacc.2010.03.002","volume":"55","author":"HM Johnson","year":"2010","unstructured":"Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol. 2010 May 4;55(18):1988\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.002.","journal-title":"J Am Coll Cardiol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02546-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:34:19Z","timestamp":1622687659000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02546-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2546"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02546-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave written informed consent signing a specific institutional consent form; the study was approved by the institutional review board of the University of Verona (1707CESC) and conformed to the ethical guidelines of the Declaration of Helsinki as revised in 2000.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (the manuscript does not contain any individual person data).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. All authors have completed the ICMJE uniform disclosure form at\n                      \n                      (available on request from the corresponding author) and declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}